Leveraged and Inverse Daily ETFs Expected to Begin Trading on Cboe Shortly After Anthropic's Highly Anticipated IPO
NEW YORK, September 2, 2026 – Tradr ETFs, a provider of ETFs designed for sophisticated investors and professional traders, has filed a registration statement with the U.S. Securities and Exchange Commission (SEC) for the Tradr 2X Long Anthropic Daily ETF (Cboe: ANTT) and the Tradr 2X Short Anthropic Daily ETF (Cboe: ANTZ). Once the registration statement becomes effective, the funds are expected to begin trading on Cboe shortly after Anthropic completes its initial public offering.
ANTT will seek daily investment results, before fees and expenses, of 200% of the daily percentage change in the common stock of Anthropic, while ANTZ will seek daily investment results, before fees and expenses, of -200% of the daily percentage change in the common stock of Anthropic, in each case for a single day only.
"The Anthropic IPO is shaping up to be one of the largest and most closely watched AI-related public offerings to date, one that will generate strong conviction on every trading desk and in every trading community we serve," said Matt Markiewicz, Head of Product and Capital Markets at Tradr ETFs. "Whether traders believe in the Anthropic story or question the valuation, ANTT and ANTZ are designed to let them trade their view in a single ticker, around the listing and every trading day beyond it. Moments like this are exactly what Tradr's lineup was built for."
Tradr’s product line currently includes 83 leveraged ETFs, which can be accessed through most brokerage platforms and allow investors to avoid the hassle of using margin and the complexity of options trading. The firm continues its mission of providing sophisticated investors with innovative trading tools that enhance their ability to express market views with precision and efficiency.
For detailed information on Tradr ETFs and the significant risks involved with leveraged ETFs, please visit www.tradretfs.com.